• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday

    11/18/22 5:14:05 AM ET
    $ACIU
    $AFMD
    $AHPI
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACIU alert in real time by email

    Gainers

    • Satixfy Communications Ltd. (NYSE:SATX) jumped 96.4% to settle at $51.70 on Thursday.
    • Elevate Credit, Inc. (NYSE:ELVT) shares jumped 68.9% to close at $1.79 on Thursday after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million.
    • Ardelyx Inc (NASDAQ:ARDX) shares climbed 41% to close at $1.72 as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis.
    • CytomX Therapeutics, Inc. (NASDAQ:CTMX) gained 32.2% to close at $1.60 after the company and Regeneron announced a strategic research collaboration in the field of conditional bispecific therapeutics for the treatment of cancer.
    • Atour Lifestyle Holdings Limited (NASDAQ:ATAT) climbed 31% to close at $14.92.
    • NWTN Inc. (NASDAQ:NWTN) gained 29.8% to settle at $4.10.
    • Cuentas Inc. (NASDAQ:CUEN) jumped 28% to close at $0.32 after dropping 28% on Wednesday. Cuentas authorized a share repurchase program.
    • GoHealth, Inc. (NASDAQ:GOCO) gained 26.5% to close at $0.62. GoHealth recently posted a Q3 loss of $0.23 per share.
    • Conformis, Inc. (NASDAQ:CFMS) rose 26.4% to settle at $1.58. Conformis recently announced settlement of Medacta patent litigation.
    • Bath & Body Works, Inc. (NYSE:BBWI) jumped 25.2% to settle at $38.97 after the company reported better-than-expected Q3 results and raised FY22 earnings forecast.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) gained 24.3% to close at $3.2330.
    • Biodesix, Inc. (NASDAQ:BDSX) gained 23.5% to close at $1.42. Biodesix announced pricing of $35.1 million upsized public offering of 30.5 million shares of common stock at a price of $1.15 per share.
    • Stryve Foods, Inc. (NASDAQ:SNAX) rose 22.7% to close at $0.50. Stryve Foods recently reported worse-than-expected Q3 sales results.
    • Holley Inc. (NYSE:HLLY) gained 21.3% to settle at $2.91. Holley recently reported a third-quarter FY22 sales decline of 3.1% year-on-year to $154.78 million.
    • Cartesian Growth Corporation (NASDAQ:GLBL) shares climbed 20.9% to close at $10.41 after dropping over 15% on Wednesday.
    • Gaotu Techedu Inc. (NYSE:GOTU) gained 20.4% to close at $1.10.
    • RLX Technology Inc. (NYSE:RLX) rose 20.1% to close at $1.73 after the company reported Q3 financial results.
    • Charah Solutions, Inc. (NYSE:CHRA) gained 18.9% to close at $0.69. Charah Solutions recently reported mixed Q3 results.
    • Compugen Ltd. (NASDAQ:CGEN) rose 17.9% to close at $1.05.
    • LexinFintech Holdings Ltd. (NASDAQ:LX) climbed 17.2% to close at $1.84. LexinFintech Holdings posted Q3 operating revenue of RMB2,690 million.
    • Upexi, Inc. (NASDAQ:UPXI) gained 16.8% to settle at $4.530. Upexi recently posted a Q1 loss of $0.16 per share.
    • uCloudlink Group Inc. (NYSE:UCL) climbed 16.7% to close at $2.24. UCLOUDLINK regained Nasdaq compliance regarding minimum market value of publicly held shares.
    • OmniAb, Inc. (NASDAQ:OABI) gained 16.7% to close at $2.86. OmniAb recently posted Q3 sales of $6.90 million.
    • Draganfly Inc. (NASDAQ:DPRO) rose 16.5% to settle at $0.68.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) jumped 16.2% to close at $1.22. NRX Pharmaceuticals recently posted a Q3 loss of $0.14 per share.
    • Paltalk, Inc. (NASDAQ:PALT) gained 16.1% to close at $1.73. The company recently posted strong Q3 sales.
    • FlexShopper, Inc. (NASDAQ:FPAY) rose 15.6% to close at $1.2133.
    • Fossil Group, Inc. (NASDAQ:FOSL) jumped 15.5% to close at $5.28. Fossil Group recently reported better-than-expected Q3 sales results.
    • Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) gained 15.3% to settle at $0.83. Foresight Autonomous signed a joint development and supply agreement with SUNWAY-AI Technology (Changzhou) Co., Ltd.
    • Macy's, Inc. (NYSE:M) surged 15% to close at $22.67 after the company reported better-than-expected Q3 EPS and sales results and raised FY22 EPS guidance.
    • AC Immune SA (NASDAQ:ACIU) gained 14.8% to close at $2.94.
    • Tencent Music Entertainment Group (NYSE:TME) jumped 13.1% to settle at $5.96 amid strength in Alibaba, which gained following Q2 results.
    • Theratechnologies Inc. (NASDAQ:THTX) rose 11.6% to close at $2.12. Cantor Fitzgerald initiated coverage on Theratechnologies with an Overweight rating and announced a price target of $9.
    • Nano Labs Ltd (NASDAQ:NA) gained 6.7% to close at $1.44 following Q3 results.
    • Cisco Systems, Inc. (NASDAQ:CSCO) rose 5% to close at $46.59 after the company reported better-than-expected Q1 results.

     

    Losers

    • Inotiv, Inc. (NASDAQ:NOTV) shares dipped 57% to close at $6.82 on Thursday after the company announced the U.S. Attorney's Office for the Southern District of Florida has criminally charged employees of the co.'s principal supplier of non-human primates, along with two Cambodian officials, with conspiring to illegally import non-human primates into the U.S.
    • Golden Sun Education Group Limited (NASDAQ:GSUN) dipped 46.3% to close at $2.31.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) shares fell 45.9% to close at $1.13.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) fell 45.1% to close at $0.9830.
    • Lightning eMotors, Inc. (NYSE:ZEV) fell 40.2% to close at $0.6642.
    • Bioventus Inc. (NASDAQ:BVS) dipped 33.7% to close at $1.97.
    • Fast Radius, Inc. (NASDAQ:FSRD) shares declined 33.3% to close at $0.14 on continued volatility after the company recently established a timeline for a Chapter 11 sale process. The company’s stock jumped 106% on Wednesday.
    • Venus Concept Inc. (NASDAQ:VERO) dropped 22.8% to settle at $0.1643. The company recently posted downbeat quarterly sales.
    • Atreca, Inc. (NASDAQ:BCEL) fell 21.8% to close at $1.15. Atreca recently posted a Q3 loss of $0.60 per share.
    • Tenaya Therapeutics, Inc. (NASDAQ:TNYA) declined 21.6% to close at $2.50 after the company announced pricing of a public offering of 22,613,307 shares of common stock at a price of $2.60 per share.
    • SKYX Platforms Corp. (NASDAQ:SKYX) dropped 20.1% to close at $2.51.
    • Otonomy, Inc. (NASDAQ:OTIC) declined 19.3% to settle at $0.1030. Otonomy recently posted a Q3 loss of $0.18 per share.
    • Trinity Place Holdings Inc. (NYSE:TPHS) fell 19.1% to close at $0.4450.
    • Myomo, Inc. (NYSE:MYO) dropped 18.8% to close at $0.69. Myomo recently posted aQ3 loss of $0.40 per share.
    • Allied Healthcare Products, Inc. (NASDAQ:AHPI) fell 18.4% to close at $1.20.
    • BIT Mining Limited (NYSE:BTCM) declined 17.9% to close at $0.2298 after the company reported Q3 sales results down from last year.
    • Bionomics Limited (NASDAQ:BNOX) fell 17.2% to close at $7.02 after the company reported pricing of underwritten offering of 641,026 American Depositary Shares in the U.S. at a price of $7.80 per ADS.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 17.1% to close at $0.1161 after jumping around 12% on Wednesday.
    • Motorsport Games Inc. (NASDAQ:MSGM) dropped 16.3% to close at $5.71.
    • DZS Inc. (NASDAQ:DZSI) fell 15.9% to close at $11.47 after the company announced pricing of a roughly $28.8 million public offering of 3,377,315 shares at a price of $11.50 per share.
    • SOBR Safe, Inc. (NASDAQ:SOBR) declined 15.8% to close at $1.22.
    • Global-e Online Ltd. (NASDAQ:GLBE) dropped 15.5% to settle at $20.73 after the company reported worse-than-expected Q3 EPS results.
    • Codexis, Inc. (NASDAQ:CDXS) fell 15.3% to close at $5.19. Codexis recently reported better-than-expected Q3 EPS and sales results.
    • BT Brands, Inc. (NASDAQ:BTBD) declined 14.4% to close at $1.72. BT Brands recently posted Q3 loss of $0.03 per share.
    • Affimed N.V. (NASDAQ:AFMD) fell 14.3% to close at $2.10.
    • IGM Biosciences, Inc. (NASDAQ:IGMS) fell 14.2% to settle at $22.05.
    • TDCX Inc. (NYSE:TDCX) dipped 13.8% to close at $11.39.
    • Dunxin Financial Holdings Limited (NYSE:DXF) dropped 13.2% to close at $0.2046.
    • BrightView Holdings, Inc. (NYSE:BV) fell 12.8% to close at $7.83 following weak quarterly results.
    • Tattooed Chef, Inc. (NASDAQ:TTCF) fell 12.4% to close at $2.40. Tattooed Chef recently reported Q3 EPS and sales results were down year over year.
    • Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) declined 11.8% to close at $17.17.
    • Oak Street Health, Inc. (NYSE:OSH) dropped 11.7% to settle at $19.77. Oak Street Health recently reported better-than-expected Q3 EPS and sales results.
    • Inhibrx, Inc. (NASDAQ:INBX) fell 11.5% to close at $29.20.
    • Membership Collective Group Inc. (NYSE:MCG) declined 11.1% to close at $3.43. JP Morgan downgraded Membership Collective from Overweight to Neutral and lowered the price target from $9 to $7.
    • Kinnate Biopharma Inc. (NASDAQ:KNTE) dropped 11% to close at $8.61. Stifel downgraded Kinnate Biopharma from Buy to Hold and lowered the price target from $35 to $11.
    • Ormat Technologies, Inc. (NYSE:ORA) fell 10.2% to close at $90.01. Ormat reported pricing of upsized public offering of 3.75 million shares of common stock on behalf of stockholder ORIX Corporation at a price of $90 per share.
    • Editas Medicine, Inc. (NASDAQ:EDIT) dropped 10.1% to close at $11.01 after the company announced clinical data from the Phase 1/2 BRILLIANCE trial of EDIT-101.
    • SenesTech, Inc. (NASDAQ:SNES) shares fell 9.2% to close at $2.95. SenesTech reported pricing of $5 million public offering.
    • Audacy, Inc. (NYSE:AUD) fell 8.4% to close at $0.3469.
    • Vaccitech plc (NASDAQ:VACC) fell 6.2% to close at $2.26. Vaccitech recently posted Q3 EPS of $0.22.
    • EZCORP, Inc. (NASDAQ:EZPW) fell 3.8% to close at $9.41 after the company reported Q4 results.
    Get the next $ACIU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACIU
    $AFMD
    $AHPI
    $ARDX

    CompanyDatePrice TargetRatingAnalyst
    Bath & Body Works Inc.
    $BBWI
    2/17/2026$25.00Buy → Neutral
    Citigroup
    Ormat Technologies Inc.
    $ORA
    2/13/2026$130.00Buy → Hold
    Jefferies
    Bioventus Inc.
    $BVS
    2/9/2026$13.00Outperform
    Barrington Research
    Cisco Systems Inc.
    $CSCO
    1/26/2026$100.00In-line → Outperform
    Evercore ISI
    CytomX Therapeutics Inc.
    $CTMX
    1/20/2026$10.00Buy
    Guggenheim
    Macy's Inc
    $M
    1/14/2026$27.00Buy
    Jefferies
    Bath & Body Works Inc.
    $BBWI
    1/14/2026$24.00Hold
    Jefferies
    Ormat Technologies Inc.
    $ORA
    1/9/2026$130.00Hold → Buy
    TD Cowen
    More analyst ratings

    $ACIU
    $AFMD
    $AHPI
    $ARDX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Finance Higa Tomohiro sold $2,231 worth of shares (3,469 units at $0.64), decreasing direct ownership by 3% to 119,752 units (SEC Form 4)

    4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)

    2/17/26 7:15:32 PM ET
    $TNYA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Executive Officer Ali Faraz sold $9,557 worth of shares (14,862 units at $0.64), decreasing direct ownership by 3% to 443,404 units (SEC Form 4)

    4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)

    2/17/26 7:14:17 PM ET
    $TNYA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Medical Officer Tingley Whittemore sold $3,319 worth of shares (5,160 units at $0.64), decreasing direct ownership by 2% to 218,618 units (SEC Form 4)

    4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)

    2/17/26 7:13:30 PM ET
    $TNYA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACIU
    $AFMD
    $AHPI
    $ARDX
    SEC Filings

    View All

    SEC Form 144 filed by Tenaya Therapeutics Inc.

    144 - Tenaya Therapeutics, Inc. (0001858848) (Subject)

    2/17/26 7:12:31 PM ET
    $TNYA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by CytomX Therapeutics Inc.

    SCHEDULE 13G/A - CytomX Therapeutics, Inc. (0001501989) (Subject)

    2/17/26 6:23:44 PM ET
    $CTMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by AC Immune SA

    6-K - AC Immune SA (0001651625) (Filer)

    2/17/26 4:36:17 PM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACIU
    $AFMD
    $AHPI
    $ARDX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bath & Body Works downgraded by Citigroup with a new price target

    Citigroup downgraded Bath & Body Works from Buy to Neutral and set a new price target of $25.00

    2/17/26 8:12:52 AM ET
    $BBWI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Ormat Tech downgraded by Jefferies with a new price target

    Jefferies downgraded Ormat Tech from Buy to Hold and set a new price target of $130.00

    2/13/26 8:36:01 AM ET
    $ORA
    Electric Utilities: Central
    Utilities

    Barrington Research initiated coverage on Bioventus with a new price target

    Barrington Research initiated coverage of Bioventus with a rating of Outperform and set a new price target of $13.00

    2/9/26 8:08:39 AM ET
    $BVS
    Medical/Dental Instruments
    Health Care

    $ACIU
    $AFMD
    $AHPI
    $ARDX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Defense Autonomy Spending Surges as AI Reshapes the Battlefield

    Issued on behalf of VisionWave HoldingsNEW YORK, Feb. 17, 2026 /CNW/ -- USANewsGroup.com News Commentary – Congress passed an $839 billion defense spending bill for fiscal 2026, the Pentagon's first full-year appropriation since fiscal 2024, directing $9.8 billion toward autonomous and unmanned systems across the Department of Defense[1]. The DOD's total IT budget reached $66 billion, a $1.8 billion increase from 2025, with every service branch increasing its AI allocation and the Navy alone adding $308 million in AI spending, a 22.7% year-over-year jump[2]. VisionWave Holdings (NASDAQ:VWAV), Ondas Holdings (NASDAQ:ONDS), Draganfly (NASDAQ:DPRO), BlackSky Technology (NYSE:BKSY), and Mercury

    2/17/26 9:59:00 AM ET
    $BKSY
    $DPRO
    $MRCY
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Aerospace
    Industrials

    Codexis to Participate in TD Cowen 46th Annual Health Care Conference

    REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the TD Cowen 46th Annual Health Care Conference, being held March 2-4, 2026, in Boston, Massachusetts. Management will participate in a fireside chat on Tuesday, March 3, 2026, at 11:50 am ET. A live webcast of the event will be available in the Investor Relations section of the Company's website, https://ir.codexis.com. A replay will be archived for 90 days following the event. About Codexis Codexis is a leading provider of enzymatic solutions for efficient

    2/17/26 9:00:00 AM ET
    $CDXS
    Major Chemicals
    Industrials

    Ormat Technologies Announces the Signing of Geothermal Portfolio PPA of Up to 150 MW to Support Google's Data Center Operations Through NV Energy

    RENO, Nev., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ormat Technologies Inc. (NYSE:ORA) (the "Company" or "Ormat"), a leading geothermal and renewable energy company, today announced that it has entered into a long-term geothermal Power Purchase Agreement (PPA) with NV Energy to support Google's operations in Nevada with up to 150MW of new geothermal capacity. The PPA, which will cover a multi-project portfolio, is enabled through NV Energy's Clean Transition Tariff (CTT) and is subject to approval by the Public Utilities Commission of Nevada (PUCN), expected in the second half of 2026. The agreement dually supports Ormat's long-term growth strategy and trajectory, enabling the development of mul

    2/17/26 8:44:00 AM ET
    $ORA
    Electric Utilities: Central
    Utilities

    $ACIU
    $AFMD
    $AHPI
    $ARDX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Director Cornog William L bought $67,300 worth of shares (5,000 units at $13.46) (SEC Form 4)

    4 - BrightView Holdings, Inc. (0001734713) (Issuer)

    2/9/26 4:30:07 PM ET
    $BV
    Real Estate

    Large owner Glenbrook Capital Management bought $15,480 worth of shares (8,569 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/6/26 5:40:20 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $ACIU
    $AFMD
    $AHPI
    $ARDX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACIU
    $AFMD
    $AHPI
    $ARDX
    Financials

    Live finance-specific insights

    View All

    Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026

    HOLON, Israel, Feb. 17, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today announced that the Company will release its fourth quarter and full year 2025 financial results on Monday, March 2, 2026, before the U.S. financial markets open. Management will host a conference call and webcast to review the results and provide a corporate update at 8:30 AM ET. To access the live conference call by telephone, please dial 1-866-744-5399 from the U.S., or +972-3-918-0644 internationally. The call will be available via live webcast through Compugen's website, which is l

    2/17/26 7:00:00 AM ET
    $CGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Gaotu Techedu to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 5, 2026

    BEIJING, Feb. 13, 2026 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE:GOTU) ("Gaotu" or the "Company"), a leading technology-driven education company in China focused on enabling lifelong learning through AI-powered solutions, today announced that it will report its financial results for the fourth quarter and fiscal year 2025 ended December 31, 2025, before U.S. markets open on Thursday, March 5, 2026. Gaotu's management will hold an earnings conference call at 8:00 AM U.S. Eastern Time on Thursday, March 5, 2026 (9:00 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows: International: +1-412-317-6061 United States: +1-888-317-6003 Hong Ko

    2/13/26 4:00:00 AM ET
    $GOTU
    Other Consumer Services
    Real Estate

    Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    LOUISVILLE, Colo., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025 after the close of trading on Thursday, February 26. Biodesix management will host a conference call and webcast to discuss its financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. Listeners can register for the webcast via this link. Analysts who wish to participate in the question and answer session should use this link. A replay of the webcast will be available via the company's investor website approximately t

    2/12/26 6:00:00 AM ET
    $BDSX
    Medical Specialities
    Health Care

    $ACIU
    $AFMD
    $AHPI
    $ARDX
    Leadership Updates

    Live Leadership Updates

    View All

    Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors

    HOLON, Israel, Feb. 12, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today announced the appointment of Michele Holcomb, Ph.D., as a new independent director, effective February 11, 2026. "On behalf of Compugen's Board of Directors, I am delighted to welcome Michele to the Board," said Anat Cohen-Dayag, Ph.D., Executive Chair, Compugen. "Michele brings more than three decades of experience spanning the biotech, pharmaceuticals and healthcare services industries. Her unique blend of strategic insights, corporate development, innovation and firsthand operation

    2/12/26 7:00:00 AM ET
    $CGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FOSSIL GROUP, INC. APPOINTS SHANNON FREEZE AS CHIEF PEOPLE AND COMMUNICATIONS OFFICER

    RICHARDSON, Texas, Feb. 9, 2026 /PRNewswire/ -- Fossil Group, Inc. (NASDAQ:FOSL) ("Fossil" or the "Company") today announced the appointment of Shannon Freeze as Chief People and Communications Officer and a member of the Executive Leadership Team, reporting to CEO Franco Fogliato, effective February 23, 2026. In this role, she will oversee global communications and engagement, diversity and belonging, human resources, talent management, and total rewards. "We're thrilled to welcome Shannon to Fossil Group. As Chief People and Communications Officer and a member of the Executi

    2/9/26 9:00:00 AM ET
    $FOSL
    Consumer Specialties
    Consumer Discretionary

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $ACIU
    $AFMD
    $AHPI
    $ARDX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Rocket Pharmaceuticals Inc.

    SC 13D/A - ROCKET PHARMACEUTICALS, INC. (0001281895) (Subject)

    12/16/24 7:51:51 PM ET
    $RCKT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by AC Immune SA

    SC 13G/A - AC Immune SA (0001651625) (Subject)

    12/13/24 5:15:16 PM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Ormat Technologies Inc.

    SC 13D/A - ORMAT TECHNOLOGIES, INC. (0001296445) (Subject)

    12/13/24 4:05:21 PM ET
    $ORA
    Electric Utilities: Central
    Utilities